Pencil‐beam scanning proton therapy for the treatment of glomus jugulare tumours

INTRODUCTION: Glomus jugulare tumours (GJT) are benign tumours that arise locally and destructively in the base of the skull and can be successfully treated with radiotherapy. Patients have a long‐life expectancy and the late effects of radiotherapy can be serious. Proton radiotherapy reduces doses to critical organs and can reduce late side effects of radiotherapy. The aim of this study was to report feasibility and early clinical results of 12 patients treated using proton therapy. METHODS: Between December 2013 and June 2019, 12 patients (pts) with GJT (median volume 20.4 cm(3); range 8.5–41 cm(3)) were treated with intensity modulated proton therapy (IMPT). Median dose was 54 GyE (Gray Equivalents) (50–60 GyE) with daily fractions of 2 GyE. Twelve patients were analysed with a median follow‐up time of 42.2 months (11.3–86.7). Feasibility, dosimetric parameters, acute and late toxicity and local effect on tumour were evaluated in this retrospective study. RESULTS: All patients finished treatment without interruption, with excellent dosimetric parameters and mild acute toxicity. Stabilisation of tumour size was detected on MRI in all patients. No changes in symptoms were observed in comparison with pre‐treatment conditions. No late effects of radiotherapy were observed. CONCLUSION: Pencil‐beam scanning proton radiotherapy is highly feasible in the treatment of large GJT with mild acute toxicity and promising short‐term results. Longer follow‐up and larger patient cohorts are required to further identify the role of pencil‐beam scanning (PBS) for this indication.